Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:29 AM
Ignite Modification Date:
2025-12-25 @ 3:29 AM
NCT ID:
NCT06087705
Eligibility Criteria:
Inclusion Criteria:
* Adult patient
* Patient with radiologically characterized gonarthrosis (stages Kellgren \& Lawrence grades I to III)
* Patient with walking pain (WOMAC A1) at least equal to 2 on the Likert scale 0-4
* Patient to benefit from an injection of SYNOVIUM HCS as part of his treatment
* Patient agreeing to participate in the study
* Patient affiliated to a social security scheme or benefiting from such a scheme
Exclusion Criteria:
* Viscosupplementation less than 6 months old
* Intra-articular corticosteroid injection less than 2 months old
* Inflammatory arthritis or active infectious of the knee studied
* History of surgery of the lower limb concerned
* Kellgren \& Lawrence grades not defined
* Known hypersensitivity to hyaluronic acid or chondroitin sulfate
* Pregnant or breastfeeding women
* Patient under guardianship, curatorship or judicial safeguard
* Patient participating in another clinical investigation, at the time of inclusion
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
90 Years
Study:
NCT06087705
Study Brief:
Protocol Section:
NCT06087705